Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02745548 · ClinicalTrials.gov registry record
Bronchial Mapping (GCC 1635)
A clinical trial, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- 23
- Enrollment target
NCT02745548: Clinical Trial study, sponsored by University of Maryland, Baltimore.
NCT02745548 is a clinical trial that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02745548 was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- 23 participants
- Enrollment target
Study Summary
In order to better understand radiation-induced lung toxicity, the investigator proposes a novel functional avoidance approach that incorporates central as well as peripheral BSS segments in the treatment planning process in order to quantify and account for their respective radiosensitivities. Specifically, the investigator proposes a systematic study that involves acquiring pre- and post-SAbR high-resolution CT and SPECT V/Q scans from lung cancer patients who receive radiotherapy, followed by auto-segmentation of the BSS elements using virtual bronchoscopy.
Primary Outcome
Evaluating the association of RT and how branching structures change in lung function
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-06-01 |
| Est. Completion | 2024-10-02 |
Why NCT02745548 stopped before completion
NCT02745548 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02745548 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02745548 about?
NCT02745548 is a clinical study titled "Bronchial Mapping (GCC 1635)". In order to better understand radiation-induced lung toxicity, the investigator proposes a novel functional avoidance approach that incorporates central as well as peripheral BSS segments in the treatment planning process in order to quantify and account for their respective radiosensitivities. Spec...
What is the current status of trial NCT02745548?
This trial is currently terminated. The enrollment target is 23 participants. The study started on 2017-06-01. Estimated completion is 2024-10-02.
Who is sponsoring clinical trial NCT02745548?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI